Showing posts with label DMA. Show all posts
Showing posts with label DMA. Show all posts

Tuesday, July 8, 2014

Using Data Analysis to Shape Your Media Strategy


My colleague Don recently wrote a blog post about the importance of doing reporting and analysis throughout the course of a patient recruitment campaign for a clinical trial. As a data analyst, I could not agree more!
One of my first enrollment campaign analyses illustrated the importance of analyzing enrollment data. As part of this final analysis of a recruitment campaign for a clinical trial involving patients with multiple sclerosis, we compared advertising costs per referral in different-sized markets.
Historically, when it comes to broadcast media advertising, we have seen the best return on investment in mid-sized markets. This makes intuitive sense: The effort (i.e., cost) needed to turn up patients with a rare condition in a city of 100,000 can be enormous. Planning a media buy in large markets, such as the New York metropolitan area, in order to recruit for a study site on Long Island can be equally expensive.
For this particular multiple sclerosis trial, a first look at media advertising costs showed a fairly linear “dose-response” relationship between market size and costs per referral:

Cost per referral - Offline advertising only
However, when digital advertising referrals and costs were added in to the analysis, the relationship between cost per referral and DMA population weakened considerably:

Cost per referral - Both online and offline advertising


This indicated that digital advertising tactics were very cost-effective for the enrollment campaign, regardless of the target markets’ population size.

Looking exclusively at cost per online referral by population size confirmed that digital advertising yielded a fairly consistent cost per referral regardless of market size:
Cost per referral - Online advertising only

This small analysis confirmed that digital advertising can be a smart advertising choice for very large markets, not only for multiple sclerosis, but also for a variety of other therapeutic conditions. All the more reason why incorporating data analysis into your decision-making process leads to more cost-effective enrollment campaigns!